CONTR 2026 260564 CBAM-1 EXP AMC 2210/2025 (1326/2025 SUM NIRSEVIMAB)
TED · 504647-2026Award noticeawardedNo deadline given
Buyer
NameServicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves
CountryES
Published2026-07-21
Deadline—
Value
Estimated€1,658,000 · 1,658,000 EUR
Awarded€1,724,320 · 1,724,320 EUR
WinnerSANOFI-AVENTIS, S.A
Who already wins at this buyer
Firms with recorded awards from Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| MEDTRONIC IBÉRICA, S.A. | 2 | €1,020,850 | 2026-07-02 |
| Alnylam Pharmaceuticals Spain, S.L. | 2 | €235,973 | 2026-07-14 |
| NOVARTIS FARMACÉUTICA, S.A. | BAYER HISPANIA, S.L.U | PFIZER, S.L. | PIERRE FABRE IBERICA S.A | RECORDATI RARE DISEASES SPAIN, S.L.U. | ROCHE FARMA, S.A.U. | SANDOZ FARMACEUTICA, S.A. | TAKEDA FARMACEUTICA ESPAÑA, S.A | AUROVITAS SPAIN S.A. | 1 | €8,000,046 | 2026-06-12 |
| ABBOTT LABORATORIES S.A. | 1 | €4,876,178 | 2026-06-02 |
| PFIZER S.L.U. | 1 | €4,876,178 | 2026-06-03 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
CBAM-1. GRANADA. EXP. 1326/2025 -Acuerdo marco, con una única empresa, por el que se fijan las condiciones para el suministro de tracto sucesivo y precio unitario para la adquisición del medicamento nirsevimab, destinado a los centros sanitarios del Servicio Andaluz de Salud